Braun S R, Flaherty D K, Burrell R, Rankin J
Am J Med. 1983 Apr;74(4):535-9. doi: 10.1016/0002-9343(83)91006-9.
The presence of anti-lung antibody was evaluated in 20 patients with farmer's lung disease. Antibody was found in 14. In patients with disease of less than five years' duration, there was no evidence of any significant differences in vital capacity, total lung capacity, diffusion capacity, and PaO2 between those with and without anti-lung antibody. However, in patients with disease of longer than five years' duration, the diffusion capacity was lower in the anti-lung antibody-positive group (p less than 0.05). The prevalence of abnormalities of vital capacity and diffusion capacity and fibrosis on chest roentgenograms was higher in those who had anti-lung antibody and disease of more than five years' duration. The study suggests that anti-lung antibody is present before permanent measurable physiologic abnormality occurs and may potentiate the pulmonary damage during subsequent episodes.
对20例农民肺疾病患者检测了抗肺抗体。14例患者检测到抗体。病程小于5年的患者中,有抗肺抗体和无抗肺抗体者在肺活量、肺总量、弥散功能和动脉血氧分压方面均无显著差异。然而,病程超过5年的患者中,抗肺抗体阳性组的弥散功能较低(p<0.05)。抗肺抗体阳性且病程超过5年的患者肺活量、弥散功能异常及胸部X线片上纤维化的发生率更高。该研究提示抗肺抗体在出现可测量的永久性生理异常之前就已存在,且可能在后续发作中加重肺损伤。